HBLCX | JIAIX | HBLCX / JIAIX | |
Total Expense Ratio | 1.64 | 0.69 | 238% |
Annual Report Gross Expense Ratio | 1.64 | 0.81 | 202% |
Fund Existence | 19 years | 11 years | - |
Gain YTD | 8.089 | 9.662 | 84% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 250000 | 1% |
Min. Initial Investment IRA | 2000 | N/A | - |
Net Assets | 11.8B | 112M | 10,536% |
Annual Yield % from dividends | 2.58 | 5.58 | 46% |
Returns for 1 year | 1.35 | 8.66 | 16% |
Returns for 3 years | 21.22 | 38.42 | 55% |
Returns for 5 years | 11.49 | 24.09 | 48% |
Returns for 10 years | 35.29 | 51.46 | 69% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETNHX | 42.07 | 0.06 | +0.14% |
Eventide Healthcare & Life Sciences N | |||
IJPTX | 12.35 | N/A | N/A |
VY® JPMorgan Emerging Markets Equity S2 | |||
FZALX | 29.92 | N/A | N/A |
Fidelity Advisor Mega Cap Stock Z | |||
MSCUX | 11.42 | N/A | N/A |
Morgan Stanley American Resilience A | |||
AIOIX | 11.50 | -0.06 | -0.52% |
American Century International Opps Inv |